Merck Picks Up Another Win In Fosamax Bellwether

Law360, New York (November 19, 2010, 7:20 PM EST) -- Jurors returned a verdict Friday in favor of Merck & Co. Inc. in one of a handful of bellwether cases alleging the company’s osteoporosis drug Fosamax can cause bone rotting in patients’ jaws, marking the third win for Merck out of four such cases.

The jury delivered its verdict in the case filed by Judith Graves after just a few hours of deliberations Friday in the U.S. District Court for the Southern District of New York, finding that the company is not responsible for her alleged...
To view the full article, register now.